| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 1,949.0 | 2,096.0 |
| Gross profit | 1,062.0 | 1,135.0 |
| Profit before tax | -11.0 | 1,514.0 |
| Net income | -12.0 | 1,266.0 |
| EPS (diluted, $ a share) | $-0.07 | $7.22 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -7.0% |
|---|---|
| Gross margin | 54.5% |
| Operating margin | 3.5% |
10-Q filed with the SEC, NYSE: SOLV. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Solventum Corp: key numbers
- Share price
- $88.65Close, Nov 16
- Market cap
- $15B
- Shares outstanding
- 169.74MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Solventum Corp
All →Solventum Earnings Call: Key Takeaways
Solventum delivered a solid Q3, completing 90% of its 3M separation and raising full-year EPS guidance despite complex ERP cutover headwinds and planned portfolio divestitures.
- Call
- Nov 5, 2026, 4:30 PM ET
Solventum Financial Results
Solventum reported Q3 2026 financial results with net sales of $1.9 billion, a 7.0% decrease primarily due to the impact of advance orders placed in the prior quarter. Despite the sales decline, the company raised its full-year adjusted EPS guidance and reported that its separation from 3M is now more than 90% complete.
- Term
- Q3 2026
“Solventum delivered third quarter results ahead of our expectations, with every segment contributing, even as we completed our largest ERP cutover; we expect to be near the top end of our full-year organic sales growth range, and are raising our full-year adjusted earnings per share outlook.”
Bryan Hanson, chief executive officer of Solventum
“With separation now more than 90% complete and our growth drivers gaining momentum, we are well positioned to accelerate sales growth and expand margins. We have differentiated innovation, a strong pipeline of new products and a significant opportunity to expand penetration of our existing brands with customers we already serve.”
Bryan Hanson, chief executive officer of Solventum